Proof-of-concept HIV immunotherapy study passes Phase 1 safety trial
Preliminary results from a phase I clinical trial have demonstrated the safety and tolerability of a cell therapy involving the ex vivo expansion of T cells and their subsequent infusion into HIV-infected individuals previously treated with antiretroviral therapy (ART).
from Latest Science News -- ScienceDaily https://ift.tt/2OMAuMO
from Latest Science News -- ScienceDaily https://ift.tt/2OMAuMO
Comments
Post a Comment